Proton pump inhibitors and the risk of colorectal cancer (Q38459132)

3 September 2017

Proton pump inhibitors and the risk of colorectal cancer (English)

1 reference

3 September 2017

1 reference

7

Ernst J Kuipers

1 reference

3 September 2017

5

Peter D Siersema

1 reference

3 September 2017

6

Miriam C J M Sturkenboom

1 reference

3 September 2017

Eva M van Soest

1

1 reference

3 September 2017

Leo G M van Rossum

series ordinal

2

1 reference

3 September 2017

Jeanne P Dieleman

series ordinal

3

1 reference

3 September 2017

Martijn G H van Oijen

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

5 December 2007

1 reference

The American Journal of Gastroenterology

3 September 2017

1 reference

3 September 2017

103

1 reference

3 September 2017

4

1 reference

3 September 2017

966-973

1 reference

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

3 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Processing and proliferative effects of human progastrin in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Cancer risk following pernicious anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Helicobacter pylori infection and colorectal cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Gastrin and colorectal cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Expression, processing, and secretion of gastrin in patients with colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Review article: gastrin and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Duodenal bacterial overgrowth during treatment in outpatients with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Bile salt biotransformations by human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Persistence and adherence to proton pump inhibitors in daily clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Chronic proton pump inhibitor therapy and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

International primary care classifications: the effect of fifteen years of evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

A chronic disease score from automated pharmacy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01665.X

10.1111/J.1572-0241.2007.01665.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference